The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...

UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

Danish company Novo Nordisk's membership in a UK pharmaceutical industry body has been restored after a two-year suspension ...

Drugmakers have warned that a recent rise in the UK’s medicine sales tax has left the country “uninvestable”, as the government prepares for a summit to try to repair relationships with large ...

Novo Nordisk has been accepted back into the fold. Two years after suspending Novo, the Association of the British ...

The UK has announced plans to abolish NHS England and integrate its functions into the central government, marking a ...

On Monday, Novo Nordisk A/S NVO returned to full membership of the Association of the British Pharmaceutical Industry (ABPI) following extensive audits of the Wegovy maker's compliance procedures ...

The UK pharmaceutical intermediate market is on a steady growth trajectory, expected to reach USD 1,156.0 million in 2025 and expand to USD 1,553.2 million by 2035, reflecting a compound annual growth ...

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...

Baclofen is a muscle relaxant primarily prescribed to treat muscle spasms, cramping, and tightness associated with multiple ...